tiprankstipranks
AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
US Market

AXIM Biotechnologies (AXIM) Financial Statements

151 Followers

AXIM Biotechnologies Financial Overview

AXIM Biotechnologies's market cap is currently ―. The company's EPS TTM is $-0.024; its P/E ratio is -0.60; AXIM Biotechnologies is scheduled to report earnings on March 19, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 9.58K$ 9.93K-$ 1.31K$ 0.00
Gross Profit$ 9.58K$ 9.93K-$ 1.31K-
EBIT$ 442.95K$ -2.94M-$ -1.93M$ -1.11M
EBITDA$ 549.70K--$ -1.82M$ -1.01M
Net Income Common Stockholders$ 328.47K$ -3.72M-$ -2.03M$ -1.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.22K$ 97.50K$ 47.28K$ 163.75K$ 65.16K
Total Assets$ 4.04M$ 4.25M$ 4.21M$ 4.48M$ 4.52M
Total Debt$ 4.22M$ 4.17M$ 1.40M$ 5.61M$ 5.59M
Net Debt$ 4.20M$ 4.08M$ 1.36M$ 5.45M$ 5.53M
Total Liabilities$ 10.00M$ 14.00M$ 9.04M$ 8.86M$ 8.25M
Stockholders Equity$ -5.96M$ -9.75M$ -4.83M$ -4.38M$ -3.73M
Cash Flow-
Free Cash Flow$ -264.50K--$ -323.94K$ -709.88K
Operating Cash Flow$ -264.50K--$ -321.23K$ -703.88K
Investing Cash Flow---$ -2.71K$ -6.00K
Financing Cash Flow$ 190.22K--$ 422.52K$ 367.00K
Currency in USD

AXIM Biotechnologies Earnings and Revenue History

AXIM Biotechnologies Debt to Assets

AXIM Biotechnologies Cash Flow

AXIM Biotechnologies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis